Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aα chain truncation causing decreased plasma expression and impaired fibrin polymerisation

Thrombosis and Haemostasis

Volumn 96, Issue 1, 2006, Pages 88-89

  Brennan, Stephen O ^a   Mosesson, Michael W ^b   Lowen, Robin ^a   Frantz, Christopher ^c  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN VARIANT; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ARTICLE; BLOOD CLOTTING TEST; BRAIN SURGERY; CASE REPORT; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; DYSFIBRINOGENEMIA; FEMALE; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; HUMAN; LUNG EMBOLISM; MENORRHAGIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; THROMBIN TIME;

ADOLESCENT; AFIBRINOGENEMIA; CODON, NONSENSE; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HEMORRHAGE; HUMANS;

EID: 33746683106     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-11-0749     Document Type: Article

References (16)

1. Mosesson MW. Hereditary Fibrinogen Abnormalities. In Williams Hematology. 7th Ed. McGraw-Hill, New York, 2005; 1909-27.
2. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904.
3. Neerman-Arbez M, de Moerloose P, Bridel C, et al. Mutations in the fibrinogen A alpha gene account for the majority of cases of congenital afibrinogenemia. Blood 2000; 96: 149-52.
4. Hanss M, Biot F. A Database For Human Fibrinogen Variants. Ann NY Acad Sci 2001; 936: 89-90. http://www.geht.org/databaseang/fibrinogen
5. Ridgway HJ, Brennan SO, Faed J M, et al. Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol 1997; 98: 632-9.
6. Lefebvre P, Velasco PT, Dear A, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen Aα VS4+1 G>T mutation and an AαGln328 truncation (fibrinogen Keokuk). Blood 2004; 103: 2571-6.
7. 461 AAA → Stop TAA). Blood 1992; 80: 1972-9.
8. Ridgway HJ, Brennan SO, Gibbons S, et al. Fibrinogen Lincoln: a new truncated α chain variant with delayed clotting. Br J Haematol 1996; 93: 177-84.
9. Homer VM, Mullin JL, Brennan SO, et al. Novel Aα chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerisation. J Throm Haemost 2003; 1: 1245-50.
10. Margaglione M, Vecchione G, Santacroce R, et al. Frameshift mutation in the human fibrinogen A-alpha chain gene (Aα(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. Thromb Haemost 2001; 86: 1483-8.
11. Marchi R, Meyer M, Bosch N, et al. Biophysical characterization of fibrinogen Caracas I with an Aα-chain truncation at Aα-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen. Blood Coagul Fibrinolysis 2004; 15: 285-93.
12. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78: 1055-8.
13. Furlan M, Steinmann C, Jungo, M, et al. A frameshift mutation in Exon V of the Aα-chain gene leading to truncated Aα-chains in the homozygous dysfibrinogen Milano III. J Biol Chem 1994; 269: 33129-34.
14. Mosesson MW, Siebenlist KR, Hainfeld JF, et al. The relationship between the fibrinogen D domain self-association/crosslinking site (γXL) and the fibrinogen Dusart abnormality (Aα R554C-albumin). J Clin Invest 1996; 97: 2342-50.
15. Tsurupa G, Medved L. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains. Biochemistry 2001; 40: 801-8.
16. DiOrio JP, Mosesson MW, Hernandez I, et al. Fibrinogen Marburg fibrin network structure. Microscopy Microanal 1999, Suppl 2: 1119-20.